EcoDrugPlus

Probable Histone Deacetylase 1-B

Ensembl ID : ENSAPOG00000001164
Gene Symbol: LOC110950061
4 Cross references
257 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSAPOG00000023767
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Progesterone Receptor-Like

Ensembl ID : ENSAPOG00000010040
Gene Symbol: LOC110959858
2 Cross references
205 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSAPOG00000005929
Gene Symbol: PTGDR2
1 Cross references
145 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSAPOG00000002263
Gene Symbol: PTGDR2
2 Cross references
134 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSAPOG00000001333
Gene Symbol: PTGER3
1 Cross references
196 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSAPOG00000011377
Gene Symbol: LOC110952762
3 Cross references
163 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSAPOG00000011294
Gene Symbol: LOC110966292
3 Cross references
171 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSAPOG00000006550
Gene Symbol: LOC110952239
3 Cross references
203 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSAPOG00000013996
Gene Symbol: LOC110961489
3 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSAPOG00000020665
Gene Symbol: LOC110969386
3 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSAPOG00000008807
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).